Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
  1. 4 Open-market sale President and CEO sold 19,642 shares at $4.86 ($95,460)
  2. 4 Open-market sale Chief Financial Officer sold 6,433 shares at $4.95 ($31,843)
  3. 4 Open-market sale Chief Medical Officer sold 7,764 shares at $4.95 ($38,432)
  4. 4 Open-market sale General Counsel sold 6,831 shares at $4.95 ($33,813)
  5. 4 Open-market sale Chief Business Officer sold 5,147 shares at $4.95 ($25,478)
  6. 4 Open-market sale President and CEO sold 18,338 shares at $4.95 ($90,773)
  7. 4 Open-market buy 10% owner bought 1,538,461 shares at $3.25 ($4,999,998)
  8. 4 Open-market buy President and CEO bought 6,500 shares at $3.81 ($24,765)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 24,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Chief Medical Officer sold 832 shares at $4.93 ($4,102)
  13. 4 Grant or award Director acquired 12,000 shares (grant or award)
  14. 4 Grant or award Director acquired 12,000 shares (grant or award)
  15. 4 Grant or award Director acquired 12,000 shares (grant or award)
  16. 4 Grant or award Director acquired 12,000 shares (grant or award)
  17. 4 Grant or award Director acquired 12,000 shares (grant or award)
  18. 4 Grant or award Director acquired 12,000 shares (grant or award)
  19. 4 Open-market sale Chief Business Officer sold 5,829 shares at $4.24 ($24,715)
  20. 4 Open-market sale Chief Medical Officer sold 6,416 shares at $4.24 ($27,204)

Page 7 of 18 · 354 filings